A Steady-state Pharmacokinetic Comparison Of All FK-506 Formulations

Trial Profile

A Steady-state Pharmacokinetic Comparison Of All FK-506 Formulations

Phase of Trial: Phase III

Latest Information Update: 20 Feb 2018

At a glance

  • Drugs Tacrolimus (Primary) ; Tacrolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Pharmacokinetics
  • Acronyms ASTCOFF
  • Sponsors Veloxis Pharmaceuticals
  • Most Recent Events

    • 20 Feb 2018 Results assessing Flexible Tacrolimus Drug Concentration Monitoring Approach, published in the Journal of Clinical Pharmacology
    • 24 Jun 2016 Results published in the American Journal of Transplantation
    • 16 Sep 2015 Results presented at the 17th Congress of the European Society for Organ Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top